156 related articles for article (PubMed ID: 1381509)
41. The calcineurin activity profiles of cyclosporin and tacrolimus are different in stable renal transplant patients.
Koefoed-Nielsen PB; Karamperis N; Højskov C; Poulsen JH; Jørgensen KA
Transpl Int; 2006 Oct; 19(10):821-7. PubMed ID: 16961774
[TBL] [Abstract][Full Text] [Related]
42. The effect of the immunosuppressant FK-506 on alternate pathways of T cell activation.
Bierer BE; Schreiber SL; Burakoff SJ
Eur J Immunol; 1991 Feb; 21(2):439-45. PubMed ID: 1705513
[TBL] [Abstract][Full Text] [Related]
43. Cyclosporine A, FK-506, 40-0-[2-hydroxyethyl]rapamycin and mycophenolate mofetil inhibit proliferation of human intrahepatic biliary epithelial cells in vitro.
Liu C; Schreiter T; Frilling A; Dahmen U; Broelsch CE; Gerken G; Treichel U
World J Gastroenterol; 2005 Dec; 11(48):7602-5. PubMed ID: 16437685
[TBL] [Abstract][Full Text] [Related]
44. CXCR4 tropic human immunodeficiency virus type 1 induces an apoptotic cascade in immature infected thymocytes that resembles thymocyte negative selection.
Choudhary SK; Walker RM; Powell DM; Planelles V; Walsh C; Camerini D
Virology; 2006 Sep; 352(2):268-84. PubMed ID: 16777169
[TBL] [Abstract][Full Text] [Related]
45. The immunosuppressive macrolides FK-506 and rapamycin act as reciprocal antagonists in murine T cells.
Dumont FJ; Melino MR; Staruch MJ; Koprak SL; Fischer PA; Sigal NH
J Immunol; 1990 Feb; 144(4):1418-24. PubMed ID: 1689353
[TBL] [Abstract][Full Text] [Related]
46. Does cyclosporin A affect CCR5 and CXCR4 expression in primary HIV-1-infected patients?
Biswas P; Galli A; Galli L; Tassan Din C; Vecchi A; Malnati M; Lazzarin A; Tambussi G
Cytometry B Clin Cytom; 2007 Nov; 72(6):433-41. PubMed ID: 17474134
[TBL] [Abstract][Full Text] [Related]
47. Modes of action of FK506, cyclosporin A, and rapamycin.
Morris R
Transplant Proc; 1994 Dec; 26(6):3272-5. PubMed ID: 7527964
[No Abstract] [Full Text] [Related]
48. FK506 and cyclosporin A inhibit granulocyte/macrophage colony-stimulating factor production by mononuclear cells in asthma.
Sano T; Nakamura Y; Matsunaga Y; Takahashi T; Azuma M; Okano Y; Shimizu E; Ogushi F; Sone S; Ogura T
Eur Respir J; 1995 Sep; 8(9):1473-8. PubMed ID: 8575571
[TBL] [Abstract][Full Text] [Related]
49. Antiviral properties of Ro 31-8959, an inhibitor of human immunodeficiency virus (HIV) proteinase.
Craig JC; Duncan IB; Hockley D; Grief C; Roberts NA; Mills JS
Antiviral Res; 1991 Dec; 16(4):295-305. PubMed ID: 1810306
[TBL] [Abstract][Full Text] [Related]
50. Generation of effector T cells in Hymenolepis nana-infected, FK-506-treated BALB/c mice.
Asano K; Matsuo S; Okamoto K
Immunol Lett; 1995 May; 46(1-2):195-8. PubMed ID: 7590919
[TBL] [Abstract][Full Text] [Related]
51. Novel inhibitory effects of gamma-glutamylcysteine ethyl ester against human immunodeficiency virus type 1 production and propagation.
Kubota S; Shetty S; Zhang H; Kitahara S; Pomerantz RJ
Antimicrob Agents Chemother; 1998 May; 42(5):1200-6. PubMed ID: 9593150
[TBL] [Abstract][Full Text] [Related]
52. Inhibition of human immunodeficiency virus type 1 replication and cytopathicity by synthetic soluble catecholamine melanins in vitro.
Montefiori DC; Modliszewski A; Shaff DI; Zhou J
Biochem Biophys Res Commun; 1990 Apr; 168(1):200-5. PubMed ID: 2327999
[TBL] [Abstract][Full Text] [Related]
53. Stimulation of endothelin mRNA and secretion in human endothelial cells by FK 506.
Takeda Y; Yoneda T; Ito Y; Miyamori I; Takeda R
J Cardiovasc Pharmacol; 1993; 22 Suppl 8():S310-2. PubMed ID: 7509973
[TBL] [Abstract][Full Text] [Related]
54. Human complement component factor B rescues HIV-1-infected leukemic T cells from cytopathic death.
Nozaki-Renard J; Kim T; Iino T; Tsukamoto T; Furutani-Seiki M; Tada T
Int Immunol; 1991 Apr; 3(4):403-6. PubMed ID: 1878341
[TBL] [Abstract][Full Text] [Related]
55. Aminosugar derivatives as potential anti-human immunodeficiency virus agents.
Karpas A; Fleet GW; Dwek RA; Petursson S; Namgoong SK; Ramsden NG; Jacob GS; Rademacher TW
Proc Natl Acad Sci U S A; 1988 Dec; 85(23):9229-33. PubMed ID: 3264071
[TBL] [Abstract][Full Text] [Related]
56. Down regulation of CD4 expression in cultured microglia by immunosuppressants and lipopolysaccharide.
Sawada M; Suzumura A; Marunouchi T
Biochem Biophys Res Commun; 1992 Dec; 189(2):869-76. PubMed ID: 1282000
[TBL] [Abstract][Full Text] [Related]
57. Inhibition of T-cell function by FK 506 and cyclosporine is not accompanied by alterations in intracellular calcium.
Jordan ML; Hignet S; Wright J; Hoffman RA; Starzl TE
Transplant Proc; 1991 Dec; 23(6):2950-2. PubMed ID: 1721323
[No Abstract] [Full Text] [Related]
58. Growth inhibition of HIV-1-infected cells and membrane alterations induced by phosphatidylcholine.
Willer AM; Buff K; Kleinschmidt A; Mellert W; Goebel FD; Erfle V
Res Exp Med (Berl); 1992; 192(1):65-77. PubMed ID: 1570416
[TBL] [Abstract][Full Text] [Related]
59. Lack of pharmacodynamic interaction between trimetazidine and cyclosporin A in human lymphoproliferative and mouse delayed hypersensitivity response models.
Albengres E; Tillement JP; d'Athis P; Salducci D; Chauvet-Monges AM; Crevat A
Fundam Clin Pharmacol; 1996; 10(3):264-8. PubMed ID: 8836700
[TBL] [Abstract][Full Text] [Related]
60. Reduction of HIV-1 antigen production by phosphatidylcholine containing formulations via growth inhibition of HIV-1-infected cells.
Willer A; Heinzmann U; Mellert W; Kleinschmidt A; Goebel FD; Erfle V
Res Exp Med (Berl); 1993; 193(2):123-35. PubMed ID: 8516563
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
